Cargando…

Cellular immunotherapy for refractory hematological malignancies

BACKGROUND: Acute myeloid leukemia (AML) and other aggressive refractory hematological malignancies unresponsive to upfront therapy remain difficult conditions to treat. Often, the focus of therapy is centered on achieving complete remission of disease in order to proceed with a consolidative stem c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reagan, John L, Fast, Loren D, Safran, Howard, Nevola, Martha, Winer, Eric S, Castillo, Jorge J, Butera, James N, Quesenberry, Matthew I, Young, Carolyn T, Quesenberry, Peter J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689050/ https://www.ncbi.nlm.nih.gov/pubmed/23782682 http://dx.doi.org/10.1186/1479-5876-11-150

Ejemplares similares

Nonengraftment Haploidentical Cellular Therapy for Hematologic Malignancies
por: Reagan, John L., et al.
Publicado: (2012)

Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia
por: Fast, Loren, et al.
Publicado: (2013)

Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia
por: Reagan, J L, et al.
Publicado: (2015)

Induction of anti-leukemic responses by stimulation of leukemic CD3+ cells with allogeneic stimulator cells
por: Pando, Alejandro, et al.
Publicado: (2018)

Cellular immunotherapy as a beacon of hope for hematological malignancies
por: Lee, Hyun-Ju, et al.
Publicado: (2015)

Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
por: Xu, Zhengli, et al.
Publicado: (2021)

Therapeutic Advances in Immunotherapies for Hematological Malignancies
por: Nogami, Ayako, et al.
Publicado: (2022)

Editorial: Immunotherapy for hematological malignancies in children
por: Zhou, Yusi, et al.
Publicado: (2023)

Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot study
por: Schumacher, Andrew, et al.
Publicado: (2017)

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
por: Einsele, Hermann, et al.
Publicado: (2020)

Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
por: Wang, Ji-nuo, et al.
Publicado: (2022)

Advent of CRISPR Based Immunotherapy in Hematologic Malignancies
por: Perez, RK, et al.
Publicado: (2018)

Immunotherapy in hematologic malignancies: past, present, and future
por: Im, Annie, et al.
Publicado: (2017)

NK Cell-Based Immunotherapy for Hematological Malignancies
por: Sivori, Simona, et al.
Publicado: (2019)

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
por: Roerden, Malte, et al.
Publicado: (2019)

T Cell Exhaustion and CAR-T Immunotherapy in Hematological Malignancies
por: Tang, Lu, et al.
Publicado: (2021)

Analysis of the potential effect of ponatinib on the QTc interval in patients with refractory hematological malignancies
por: Sonnichsen, Daryl, et al.
Publicado: (2013)

Stem Cell Reviews and Reports: Cancer Stem Cells and Aging Section
por: Quesenberry, Peter
Publicado: (2017)

Editorial: Linking cellular metabolism to hematological malignancies
por: He, Xiujing, et al.
Publicado: (2022)

Extracellular vesicle-mediated phenotype switching in malignant and non-malignant colon cells
por: Mulvey, Hillary E., et al.
Publicado: (2015)

Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches
por: Noh, Ji-Yoon, et al.
Publicado: (2020)

Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
por: Tang, Lu, et al.
Publicado: (2023)

Editorial: Epidemiological trends in hematological malignancies
por: de Lima, Marcos, et al.
Publicado: (2023)

SPC methods for quality improvement
por: Quesenberry, Charles P
Publicado: (1997)

Perspectives on the Potential Therapeutic Uses of Vesicles
por: Camussi, Giovanni, et al.
Publicado: (2013)

A Unique Neuropsychiatric Syndrome in Variant Hereditary Coproporphyria: Case Report and Review of the Literature
por: Baumgartner, Alex, et al.
Publicado: (2017)

Gene Modified CAR-T Cellular Therapy for Hematologic Malignancies
por: Lin, Wen-Ying, et al.
Publicado: (2020)

Development of a Patient-Centered Preference Tool for Patients With Hematologic Malignancies: Protocol for a Mixed Methods Study
por: Cole, Amy, et al.
Publicado: (2022)

Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies
por: Ye, Baixin, et al.
Publicado: (2017)

T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies
por: Janelle, Valérie, et al.
Publicado: (2020)

Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective
por: Allegra, Alessandro, et al.
Publicado: (2021)

The landscape overview of CD47-based immunotherapy for hematological malignancies
por: Yang, Hua, et al.
Publicado: (2023)

Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies
por: Tapia-Galisteo, Antonio, et al.
Publicado: (2023)

Gestational weight gain and optimal wellness (GLOW): rationale and methods for a randomized controlled trial of a lifestyle intervention among pregnant women with overweight or obesity
por: Brown, Susan D., et al.
Publicado: (2019)

Engineering naturally occurring CD7(−) T cells for the immunotherapy of hematological malignancies
por: Freiwan, Abdullah, et al.
Publicado: (2022)

Kicking butt in computer science: women in computing at Carnegie Mellon University
por: Frieze, Carol, et al.
Publicado: (2015)

Cellular Therapies for the Treatment of Hematological Malignancies; Swine Are an Ideal Preclinical Model
por: Duran-Struuck, Raimon, et al.
Publicado: (2019)

Veterinary hematology : atlas of common domestic and non-domestic species /
por: Reagan, William J.
Publicado: (2008)

The study of women, infant feeding and type 2 diabetes after GDM pregnancy and growth of their offspring (SWIFT Offspring study): prospective design, methodology and baseline characteristics
por: Gunderson, Erica P., et al.
Publicado: (2015)

Inflammation-related gene expression profiles of salivary extracellular vesicles in patients with head trauma
por: Cheng, Yan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hsu9pu884p88tbo7q41e2jb2c7